JUN 17, 2019 07:59 AM PDT

Promising Hypertension Drug for Alzheimer Disease

WRITTEN BY: Nouran Amin

In a study led by the American Heart Association, the blood pressure drug nilvadipine (a calcium channel blocker) was found to increase blood flow to the brains memory and learning center in individuals with Alzheimer's disease without adverse effects to other regions of the brain. The study was published in the journal Hypertension and indicates that a decrease in cerebral blood flow in patients with Alzheimer's can be reversed in some regions.

Alzheimer disease is a form of dementia with a risk that increases with age. Causes for Alzheimer disease still remain unknown but earlier studies have shown that blood flow to the brain declines in the early stages of Alzheimer disease. Other studies implied that possible high blood pressure treatment may reduce the risk of dementia possibly because of the beneficial effects on brain blood flow.

"This high blood pressure treatment holds promise as it doesn't appear to decrease blood flow to the brain, which could cause more harm than benefit," said study lead author Jurgen Claassen, M.D., Ph.D., associate professor at Radboud University Medical Center in Nijmegen, the Netherlands. "Even though no medical treatment is without risk, getting treatment for high blood pressure could be important to maintain brain health in patients with Alzheimer's disease."

Learn more about Alzheimer Disease:

 

 

"In the future, we need to find out whether the improvement in blood flow, especially in the hippocampus, can be used as a supportive treatment to slow down progression of Alzheimer's disease, especially in earlier stages of disease," Claassen said.

The study was the first to utilize MRI technique to observe the effects of treatment on cerebral blood flow.

Source: American Heart Association

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JAN 24, 2020
Health & Medicine
JAN 24, 2020
FDA Cautions Against Cannabis Use During Pregnancy
A recent article published by NPR addresses the rapidly growing number of females using cannabis during pregnancy. Those with tough pregnancy side effects ...
JAN 24, 2020
Drug Discovery & Development
JAN 24, 2020
Vaccine To Protect Against The Zika Virus
Scientists at The University of Texas Medical Branch at Galveston present for the first time how a single high dose vaccine can protect a pregnant mouse al...
JAN 24, 2020
Drug Discovery & Development
JAN 24, 2020
FDA Approves New Schizophrenic Drug
The US Food and Drug Administration (FDA) has approved an atypical antipsychotic Caplyta (lumateperone; Intra-Cellular Therapies) for the treating schizoph...
JAN 24, 2020
Drug Discovery & Development
JAN 24, 2020
New Drug Combo Reverses Breast Cancer
Researchers from Georgetown University have found that combining a drug used for epilepsy, bipolar disorder, and migraines with a drug used to ease blood p...
JAN 24, 2020
Cancer
JAN 24, 2020
Could salt nanoparticles kill cancer?
Could salt be the key to killing cancer cells? A new study published in Advanced Materials reports success in using sodium chloride to destroy cancer cells...
JAN 24, 2020
Drug Discovery & Development
JAN 24, 2020
A New Drug Target for Substance Abuse
Research carried out by the University of Minnesota Medical School indicates a new drug target for treating a drug addiction. Researchers note that the dru...
Loading Comments...